Not recruiting
Investigational
Phase 3 Study of Zigakibart (BION-1301) in Adults with IgA Nephropathy
Investigational
- Substances:Zigakibart
Countries:
Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Zigakibart
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Avenida Alcalde Rovira Roure 80, 25198 Lleida, Spain
Clinical trials registered at this site – none is enrolling right now.
SpainGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.